Dataset opportunity
Intelligent Implants — Medical Imaging Dataset Opportunity
Intelligent Implants 持有的中等规模医学影像数据集，可用于诊断人工智能和计算机视觉。
Score
48
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球医疗影像人工智能市场 = 2025 年为 18 亿美元，复合年增长率为 35.1%（来源：Grand View Research）
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-24
Why the FDA’s top spot could sit empty for months
medtechdive.com ↗ - 📰press2026-07-24
GE HealthCare CFO Jay Saccaro steps down
medtechdive.com ↗ - 📰press2026-07-24
Edwards posts strong TAVR sales ahead of potential Medicare coverage expansion
medtechdive.com ↗ - 📰press2026-07-23
FDA names Dexcom as first participant in digital health pilot
medtechdive.com ↗ - 📰press2026-07-22
AiM Medical Robotics names new CFO
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
医学影像数据集
Modality
影像
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — GDPR 敏感（个人身份信息审查）
Buyer persona
医疗人工智能与诊断影像公司
Intelligent Implants 持有一个独特的医学影像数据集，其中包含其 SmartFuse 临床试验的影像模态数据。该数据集通过植入物的相应物联网数据、病历和事件流得到丰富，提供了一个全面、多模态的资源，非常适合开发和验证高性能的诊断人工智能模型，用于术后脊柱融合评估等应用。
在全球医疗影像人工智能市场中，该数据具有非凡的价值，该市场在 2025 年的估值为18 亿美元，预计到 2033 年的复合年增长率将达到35.1%。[6] 尽管由于GDPR和HIPAA法规以及与临床试验站点的共同所有权而存在访问复杂性，但该数据集与特定医疗设备和患者结果的直接联系提供了高度追捧的细节和稀有性，证明了为寻求竞争优势的人工智能开发商进行谈判的努力是值得的。[11, 12] ⚠ 尽职调查（有价值的数据，可协商访问）：受 GDPR 和 HIPAA 法规约束的高度敏感医疗/健康数据；数据可能与正在进行的临床试验（SmartFuse 研究）相关；所有权可能涉及与临床试验站点/医院的共有权利。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据证实 Intelligent Implants 持有一个专有的、多模态的数据集，该数据集结合了其 SmartFuse 植入物的放射影像和实时传感器数据。这种独特的集合是专门为寻求开发先进骨科诊断人工智能的医疗人工智能公司而构建的，特别是用于验证和预测骨骼生长和融合成功。在全球医疗影像人工智能市场预计到 2025 年将达到 18 亿美元的情况下，该数据集提供了一个难得的机会，可以对临床研究数据进行算法训练，该数据将影像结果与连续的生物监测联系起来。
See dimension details ↓- Buyer Demand90
市场的爆炸式增长，预计复合年增长率为 35.1%，表明人工智能买家对高质量、经过临床验证的医学影像数据以构建下一代诊断工具的需求非常强烈且不断增长。[6]
How strongly AI builders and companies are likely to want this data, based on market signals. - Dataset Specificity90
占主导地位的“病历”，医疗保健行业，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Legal Accessibility0
个人身份信息/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=拥有，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 个数据需求信号（2 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，5 个近期外部信号 — 专有数据超出已货币化的范围
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit67
⚠ 审查 — 公司的核心业务是销售包含数据/监控服务（SmartFuse CLOUD™）的智能医疗设备，使其成为智能的销售者，而不是休眠数据的持有者。问题：公司的产品 SmartFuse® 系统是物理植入物和云平台（SmartFuse CLOUD™）的组合，该平台为医生提供实时数据；这种将数据和洞察作为产品一部分提供的业务模式被视为“销售智能”，并且是明确的排除标准；首席执行官证实他们的战略是提供一种“智能、互联的植入物，提供治疗益处和远程数据以支持实时临床决策；该公司已经在市场上销售“智能植入物”，这些植入物将硬件与数据分析相结合，而不是非数据业务中未开发数据的持有者。
- Deep Qualification90
✓ 通过 — Intelligent Implants 是一家医疗设备公司，而不是数据销售商。它持有其 SmartFuse 系统产生的极有可能且有价值的物联网和临床数据，这是其核心活动的副产品，但这些数据受到复杂的拥有权和严格的 GDPR/HIPAA 法规的约束，使得访问难以协商。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
这些证据指向由体内植入物传感器生成的专有时间序列数据，为开发预测性人工智能模型提供了前所未有的生物状况地面真实性。
Medical records / imaging
该数据集包含在正式临床研究期间收集的放射影像，为训练诊断影像算法提供了高价值、经过验证的骨骼生长视觉证据。
Event streams
持有者运营一个云平台，该平台聚合来自植入物的连续患者数据流，表明存在一个结构化、可扩展且持续的数据收集过程，非常适合纵向人工智能研究。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Coverage
Scanned sources
Deliverable
Premium dataset report
Intelligent Implants Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.8 billion in 2025, CAGR 35.1% (source: Grand View Research). Investment score 48.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Aream — 维护日志数据集机会
View opportunity →工业Geoter — 工业传感器数据集机会
View opportunity →工业Voltfang — 工业传感器数据集机会
View opportunity →